Treatments:M2 Proton Channel Inhibitor Pharmacokinetics
From Proteopedia
(Difference between revisions)
(New page: References for M2 Proton Channel Inhibitor Pharmacokinetics<ref>PMID:3662473</ref><ref>PMID:17156962</ref> <references/>) |
(New page: References for M2 Proton Channel Inhibitor Pharmacokinetics<ref>PMID:3662473</ref><ref>PMID:17156962</ref> <references/>) |
Current revision
References for M2 Proton Channel Inhibitor Pharmacokinetics[1][2]
- ↑ Anderson EL, Van Voris LP, Bartram J, Hoffman HE, Belshe RB. Pharmacokinetics of a single dose of rimantadine in young adults and children. Antimicrob Agents Chemother. 1987 Jul;31(7):1140-2. PMID:3662473
- ↑ Wang P, Liang YZ, Chen BM, Zhou N, Yi LZ, Yu Y, Yi ZB. Quantitative determination of amantadine in human plasma by liquid chromatography-mass spectrometry and the application in a bioequivalence study. J Pharm Biomed Anal. 2007 Mar 12;43(4):1519-25. Epub 2006 Dec 6. PMID:17156962 doi:10.1016/j.jpba.2006.10.044
